cover image: Drug Decriminalization, Fentanyl, and Fatal Overdoses in Oregon

Drug Decriminalization, Fentanyl, and Fatal Overdoses in Oregon

6 Nov 2024

Amid the worst fatal opioid overdose crisis in US history, many jurisdictions have explored alternatives to traditional models of arrest and incarceration for drug possession. Some states have decriminalized the personal possession of certain federally scheduled substances (e.g., cannabis, psilocybin, and buprenorphine), enacted Good Samaritan laws to shield people from arrest at the scene of an overdose when they seek help, created police programs that link people to treatment and harm reduction services, and taken de facto approaches to decriminalizing drug possession. In the most sweeping response to date, Oregon voters passed Measure 110 (M110) in November 2020, making it the first state to decriminalize the possession of all nonprescribed drugs for personal use while reallocating millions of dollars toward addiction treatment, recovery programs, housing, and harm reduction services. The measure was intended to reduce overdoses by expanding and promoting linkages to health care systems for people who use drugs while reducing entrenched racial and ethnic disparities in the enforcement of drug possession laws. Since its enactment, however, M110 has faced implementation challenges, and addiction treatment capacity has not sufficiently expanded to meet the state's needs. Police officials reported that decriminalization hampered their ability to address concerns about public drug use. In 2021, Oregon's rate of fatal overdoses increased by approximately 50 percent compared with the previous year. In response to these initial outcomes, Oregon's legislature recriminalized drug possession in March 2024, which took effect in September 2024. As other jurisdictions look to Oregon's health outcomes in considering their own policy responses to overdoses, an accurate assessment of the association between M110 and fatal overdoses is crucial.

Authors

Michael J. Zoorob, Ju Nyeong Park, Brandon del Pozo, Alex H. Kral, Barrot H. Lambdin

Related Organizations

Pages
3
Published in
United States of America

Table of Contents